Publication | Open Access

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Breast OncologyOncologyDual Her2 BlockadePharmacologyBreast CancerPharmacotherapyCancer TreatmentMedicineNeoadjuvant ChemotherapyHer2-positive Breast Cancer